RITZEY THERAPEUTICS
LIVE

Serial Number

50141274

Owner

RITZEY THERAPEUTICS INC.

Attorney

Cory Poker

Filing Date

Oct 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RITZEY THERAPEUTICS Trademark

Serial Number: 50141274

RITZEY THERAPEUTICS is a trademark filed by RITZEY THERAPEUTICS INC. on October 2, 2026. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

RITZEY THERAPEUTICS INC. (2 trademarks)

1209 ORANGE STREET
WILMINGTON, DE 19801

Entity Type: 03

Trademark Details

Filing Date

October 2, 2026

Registration Date

Not Registered

Goods & Services

Scientific research and development; Scientific research for medical purposes in the field of central nervous system disorders, metabolic disorders, or cancer; Research and development in the field of pharmaceuticals and medical treatment; Scientific research in the field of pharmaceuticals and medical treatment; Medical and scientific research in the field of central nervous system disorders, metabolic disorders, and cancer; Providing medical and scientific research information; Medical research; Providing information about medical and scientific research; Medical research in the field of central nervous system disorders, metabolic disorders, and cancer; Research and development in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research in the field of pharmaceuticals; Research and development of new products in the field of pharmaceuticals; Research and development in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical research and development; Pharmaceutical products development; Pharmaceutical research in the field of central nervous system disorders, metabolic disorders, and cancer; Research and development in the field of small molecule kinase inhibitors; Research and development in the field of treatments for central nervous system disoders; Research and development in the field of treatments for metabolic disorders; Research and development in the field of treatment of cancer; Research and development services in the field of pharmaceutical preparations; Research and development of medicines

Filing History

APPLICATION FILING RECEIPT MAILED
Oct 2, 2026 MAFR
NEW APPLICATION ENTERED
Oct 2, 2026 NWAP